The Role of food addiction and lifetime substance use on eating disorder treatment outcomes

Food addiction (FA) and substance use (SU) in eating disorders (ED) have been associated with a more dysfunctional clinical and psychopathological profile. However, their impact on treatment outcomes has been poorly explored. Therefore, this transdiagnostic study is aimed at examining whether the pr...

Descripción completa

Detalles Bibliográficos
Autores: Miranda-Olivos, Romina|||0000-0003-2360-5830, Agüera, Zaida|||0000-0003-4453-4939, Granero, Roser|||0000-0001-6308-3198, Jiménez Murcia, Susana|||0000-0002-3596-8033, Puig-Llobet, Montserrat|||0000-0002-3893-4488, Lluch-Canut, Maria Teresa, Gearhardt, Ashley N.|||0000-0003-3843-5731, Fernández Aranda, Fernando|||0000-0002-2968-9898
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:276611
Acceso en línea:https://ddd.uab.cat/record/276611
https://dx.doi.org/urn:doi:10.3390/nu15132919
Access Level:acceso abierto
Palabra clave:Food addiction
Substance use
Treatment outcomes
Eating disorders
Descripción
Sumario:Food addiction (FA) and substance use (SU) in eating disorders (ED) have been associated with a more dysfunctional clinical and psychopathological profile. However, their impact on treatment outcomes has been poorly explored. Therefore, this transdiagnostic study is aimed at examining whether the presence of FA and/or SU is associated with treatment outcomes in patients with different ED types. The results were not able to reveal significant differences in treatment outcomes between patients with and without FA and/or SU; however, the effect sizes suggest higher dropout rates in the group with both FA and SU. The predictive models of treatment outcomes showed different features associated with each group. High persistence (i.e., tendency to perseverance and inflexibility) was the personality trait most associated with poor treatment outcomes in patients without addictions. High harm avoidance and younger age at ED onset were the variables most related to poor outcomes in patients with FA or SU. Finally, in the group with both addictive behaviors (FA and SU), the younger patients presented the poorest outcomes. In conclusion, our results suggest that, regardless of presenting addictive behaviors, patients with ED may similarly benefit from treatment. However, it may be important to consider the differential predictors of each group that might guide certain treatment targets.